文献速递腹部技术与安全CT

其他癌症幸存者中的CT结肠成像筛查:按癌症类型对结直肠和结肠外发现率的影响

CT colonography screening in extracolonic cancer survivors: impact on rates of colorectal and extracolonic findings by cancer type.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本研究在160个月间纳入349例有其他癌症病史的患者(Ca+)与8859例无癌症病史对照(Ca-),比较CT结肠成像筛查中结直肠(C-RADS C2-C4)和结肠外(C-RADS E3-E4)发现率。Ca+组两类发现率均显著高于Ca-组(p=0.0283和0.0236),非小细胞肺癌、头颈癌和膀胱癌幸存者结直肠发现相对率升高,血液系统恶性肿瘤幸存者E3发现升高,妇科恶性肿瘤幸存者E4发现升高。

要点

  • 有其他癌症病史者CTC筛查结直肠C2-C4和结肠外E3-E4发现率均显著高于无癌症病史者。
  • 非小细胞肺癌(RR 3.1)、头颈癌(RR 3.4)、膀胱癌(RR 2.2)幸存者结直肠发现相对率升高。
  • 血液系统恶性肿瘤幸存者E3发现RR 2.0,妇科恶性肿瘤幸存者E4发现RR 3.4。

核心结论

  • 有其他癌症病史的患者CTC筛查中相关结直肠和结肠外发现率升高,尤其在特定癌症亚组中;作者认为这些结果可能对这类患者结直肠检查方法的选择有重要意义。

研究设计与样本

  • 回顾性比较研究,160个月间349例有其他癌症病史成人(平均年龄60.3岁,67%女性,排除271例孤立性非黑色素瘤皮肤癌)接受CTC筛查,与8859例无癌症病史对照(平均年龄57.0岁,53%女性)比较。

诊断标准与关键数值

  • 主要结局为CTC相关结直肠发现(C-RADS C2-C4)和结肠外发现(C-RADS E3-E4)的发生率;Ca+组与Ca-组结直肠发现率比较p=0.0283,结肠外发现率比较p=0.0236;非小细胞肺癌幸存者结直肠发现RR 3.1,头颈癌幸存者RR 3.4,膀胱癌幸存者RR 2.2;血液系统恶性肿瘤幸存者E3发现RR 2.0;妇科恶性肿瘤幸存者E4发现RR 3.4。

临床应用与阅片要点

  • 作者认为这些结果可能对这类患者结直肠检查方法的选择有重要意义。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the rates of colorectal and extracolonic findings at CT colonography (CTC) screening between patients with and without a personal prior history of other.

METHODS: Over a 160-month interval, 349 adults (mean age, 60.3 years; 67% female) with a positive history of extracolonic cancer [Ca(+)], excluding 271 patients with isolated non-melanoma skin cancers, underwent CTC screening. This study cohort was compared against 8859 controls (mean age, 57.0 years; 53% female) without a prior cancer history [Ca(-)]. Primary outcome measures included the rates of relevant colorectal (C-RADS C2-C4) and extracolonic (C-RADS E3-E4) findings at CTC. Wilcoxon rank sum test was used to test for statistical significance with post-hoc analysis by relative rate (RR).

RESULTS: Both colorectal (C2-C4) and extracolonic (E3-E4) findings were significantly increased in the Ca(+) group versus Ca(-) control group (p = 0.0283 and 0.0236, respectively). Positive colorectal findings were most notably increased among survivors of non-small cell lung cancer (RR 3.1), head/neck cancers (RR, 3.4), and bladder cancers (RR 2.2). The proportion of C2-C4 patients undergoing intervention in the Ca(+) cohort was not significantly different than the Ca(-). Potentially relevant extracolonic findings (E3) were increased in survivors of hematogenous malignancies (RR 2.0), while likely important extracolonic findings (E4) were increased in survivors of female gynecological malignancies (RR 3.4).

CONCLUSIONS: Relevant colorectal and extracolonic findings at CTC screening are increased in patients with a previous extracolonic cancer history, particularly among certain cancer subsets. These results may have important implications for choice of colorectal test in these patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Larson ME, Pickhardt PJ. CT colonography screening in extracolonic cancer survivors: impact on rates of colorectal and extracolonic findings by cancer type. Abdom Radiol (NY). 2019. PMID: 30066170. doi:10.1007/s00261-018-1708-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。